A group of tech executives, app developers and Silicon Valley philosophers is seeking to streamline the messy matters of the ...

Key world-class projects include development of Kodiramamurthy Stadium at Srikakulam, construction of a modern Rs 25-crore ...

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and ...

In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

US FDA clears Ascletis’ IND application for 13-week phase II study of oral small molecule GLP-1, ASC30, in participants with diabetes: Hong Kong Wednesday, January 7, 2026, 18:0 ...

Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with ...

Costco is a Strong Buy after a 20% pullback, with a new target of $1,121 and fundamentals stronger than ever. Click to read ...

Out of the total 852 projects to be taken up on PPP basis in the pipeline, 232 are Central government projects worth ₹13.15 ...

F5 promoted industry-leading application security while a nation-state breach went undisclosed, prompting a securities fraud ...

U.S FDA has accepted IND application for COMP360 in PTSD, enabling the initiation of a Phase 2b/3 (COMP202) clinical trial in patients living with PTSD.